Tuesday, December 23, 2025
ADVT 
International

Indian-origin man admits to attacking cop in Singapore

Darpan News Desk IANS, 02 Jun, 2023 01:51 PM
  • Indian-origin man admits to attacking cop in Singapore

Singapore, June 2 (IANS) An Indian-origin man in Singapore admitted to attacking a police officer in 2020 and leaving him with a bloody face, a media report said.

Nikhil M. Durgude, 25, pleaded guilty on Thursday to eight charges including one for voluntarily causing hurt to deter a public servant from his duty, The Straits Times reported.

Also charged with possessing cannabis and consuming methamphetamine, Nikhil is expected to be sentenced on June 16.

According to court documents, three officers, including Senior Staff Sergeant Chua Ming Cheng and Inspector Zheng Yiyang, went to a unit at City Suites in Balestier as part of a police operation on November 5, 2020.

They identified themselves as police to Nikhil and his accomplices, Prakash Mathivanan and Malani Naidu Prabhakar.

After a while, Prakash lunged at Staff Sergeant Chua, causing him to fall. He then hit the officer in the face and upper body, the report said.

When Inspector Zheng pointed his revolver at Prakash asking him to stop attacking, the latter grabbed his hands.

Before Chua could get up and assist Inspector Zheng, he was attacked by Nikhil, who punched and kicked him repeatedly. He fell again and Nikhil continued to assault Chua as he lay on the floor, The Straits Times reported.

"The accused did so to prevent Staff Sergeant Chua from assisting Inspector Zheng, and intending, therefore, to deter Chua from discharging his duty as such public servant," the prosecution told the court

Nikhil stopped his attack on Chua when two other officers were led into the unit after some time.

The three men were arrested and taken to the Central Police Division headquarters where the authorities detected methamphetamine in Nikhil's urine after tests.

Staff Sergeant Chua suffered a cut on the forehead and abrasions on his right elbow and left forearm, and was admitted to Singapore General Hospital for treatment.

For voluntarily causing hurt to a public servant, Nikhil could be jailed for up to seven years, caned, or fined.

MORE International ARTICLES

WATCH: France Alert as Terrorist Strikes Nice Again | "Islamic Terrorism" says President Macron

WATCH: France Alert as Terrorist Strikes Nice Again |
WATCH: A deadly terrorist attack has targeted France. According to Police, three people have been killed in a knife attack at a church in the French city of Nice.

WATCH: France Alert as Terrorist Strikes Nice Again | "Islamic Terrorism" says President Macron

Trump formally lets Canadian aluminum off hook

Trump formally lets Canadian aluminum off hook
The U.S. president formally signed a proclamation today exempting Canadian aluminum exports from punitive Section 232 tariffs.

Trump formally lets Canadian aluminum off hook

Prince Harry says ignorance no excuse for unconscious bias

Prince Harry says ignorance no excuse for unconscious bias
Harry talked about racial inequality and social justice in a video discussion with the Black Lives Matter activist Patrick Hutchinson as part of the GQ Heroes Conference, which is being broadcast this week.

Prince Harry says ignorance no excuse for unconscious bias

Halloween goes on at the White House with a few twists

Halloween goes on at the White House with a few twists
In years past, the president and first lady personally handed out candy to the costume-clad kids. This year, the treats were provided separately as participants walked along a path on the South Lawn.

Halloween goes on at the White House with a few twists

AstraZeneca resuming US testing of COVID-19 vaccine

AstraZeneca resuming US testing of COVID-19 vaccine
The AstraZenca vaccine, developed with Oxford University, is one of several coronavirus vaccine candidates in final-stage testing around the world.

AstraZeneca resuming US testing of COVID-19 vaccine

FDA approves first COVID-19 drug: antiviral remdesivir

FDA approves first COVID-19 drug: antiviral remdesivir
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

FDA approves first COVID-19 drug: antiviral remdesivir